- Home
- MYGN vs HNRG Comparison
MYGN vs HNRG Comparison
Compare MYGN & HNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- HNRG
- Stock Information
- Founded
- MYGN 1991
- HNRG 1949
- Country
- MYGN United States
- HNRG United States
- Employees
- MYGN N/A
- HNRG N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HNRG Coal Mining
- Sector
- MYGN Health Care
- HNRG Energy
- Exchange
- MYGN Nasdaq
- HNRG Nasdaq
- Market Cap
- MYGN 642.0M
- HNRG 698.9M
- IPO Year
- MYGN 1995
- HNRG N/A
- Fundamental
- Price
- MYGN $7.88
- HNRG $19.83
- Analyst Decision
- MYGN Hold
- HNRG Strong Buy
- Analyst Count
- MYGN 13
- HNRG 4
- Target Price
- MYGN $13.50
- HNRG $20.00
- AVG Volume (30 Days)
- MYGN 1.5M
- HNRG 537.9K
- Earning Date
- MYGN 11-06-2025
- HNRG 11-11-2025
- Dividend Yield
- MYGN N/A
- HNRG N/A
- EPS Growth
- MYGN N/A
- HNRG N/A
- EPS
- MYGN N/A
- HNRG N/A
- Revenue
- MYGN $832,900,000.00
- HNRG $419,451,000.00
- Revenue This Year
- MYGN $0.17
- HNRG $8.52
- Revenue Next Year
- MYGN $6.19
- HNRG $4.46
- P/E Ratio
- MYGN N/A
- HNRG N/A
- Revenue Growth
- MYGN 3.83
- HNRG N/A
- 52 Week Low
- MYGN $3.76
- HNRG $8.13
- 52 Week High
- MYGN $26.60
- HNRG $22.01
- Technical
- Relative Strength Index (RSI)
- MYGN 57.10
- HNRG 58.78
- Support Level
- MYGN $7.04
- HNRG $19.23
- Resistance Level
- MYGN $8.25
- HNRG $20.03
- Average True Range (ATR)
- MYGN 0.38
- HNRG 0.86
- MACD
- MYGN -0.06
- HNRG -0.00
- Stochastic Oscillator
- MYGN 54.77
- HNRG 62.63
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About HNRG Hallador Energy Company
Hallador Energy Co is a coal mining company with operations in Indiana, USA, and it is part of the electric power generation industry. The operations of the company are divided into two primary reportable segments, the Coal Operations and Electric Operations segments. The majority of revenue is earned from the Coal Operations segment.